Sundaram K, Murugaian J, Watson M, Sapru H
Section of Neurosurgery, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark 07103.
Brain Res. 1989 Jan 16;477(1-2):358-62. doi: 10.1016/0006-8993(89)91427-3.
Bilateral microinjections (0.2-2 nmol/site) of a potent M2 muscarinic receptor agonist, cis-methyldioxolane (CD), but not those of a relatively selective M1 receptor agonist (McN-A343; 3 nmol/site), into the intermediate portion of nucleus tractus solitarii (NTS) of pentobarbital-anesthetized rats elicited a decrease in blood pressure (23-52 mm Hg) and heart rate (16-50 bpm). Previous microinjections of a selective competitive M2 receptor antagonist (AFDX-116; 0.8 nmol/site), but not those of a potent selective M1 receptor antagonist (pirenzepine; 2 nmol/site), into the NTS blocked the effects of CD. These results indicate that the muscarinic receptors in the intermediate portion of NTS are of M2 type.
向戊巴比妥麻醉的大鼠孤束核(NTS)中间部分双侧微量注射(0.2 - 2 nmol/位点)强效M2毒蕈碱受体激动剂顺式甲基二氧戊环(CD),而非相对选择性的M1受体激动剂(McN - A343;3 nmol/位点),可引起血压下降(23 - 52 mmHg)和心率降低(16 - 50 bpm)。先前向NTS中微量注射选择性竞争性M2受体拮抗剂(AFDX - 116;0.8 nmol/位点),而非强效选择性M1受体拮抗剂(哌仑西平;2 nmol/位点),可阻断CD的作用。这些结果表明,NTS中间部分的毒蕈碱受体为M2型。